Theralink Technologies, a precision oncology company with a novel phosphoprotein-based assay for breast cancer, received College of American Pathologists (CAP) Accreditation for its Reverse Phase Protein Array lab in Golden, CO.   The Accreditation was based on results of a recent on-site inspection as part of its Accreditation review system. During the process, which is designed to ensure the highest standard of care for all laboratory patients, inspectors examined the laboratory’s reco...